News GLP-1 Drugs Cut Glaucoma Risk in Nondiabetic Obesity by Medscape • 2025/02/25 • 0 Comments GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight loss medications in patients without diabetes diagnosed with obesity. Medscape Medical News